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Europe, Milan, Italy). No stool samples were available for culture or direct toxin testing, but the patient did not have diarrhoea at any time during this admission.
The patient improved clinically over the next 72 hours, became apyrexial and was sent back to his referring hospital as his cardiological problems had been controlled. He received metronidazole for six days in total. The chest drain was removed prior to transfer, although he still had a right pleural effusion. He did not receive any further antibiotics. Appearances on chest x ray film did not change further and it was concluded that these were caused by a chronic inflammatory process. The patient was stable six months after discharge and refused further investigation of his chest disease, including further pleural taps.
Discussion
Although C difficile is well established as the major cause of pseudomembranous colitis (PMC), antibiotic associated colitis (AAC) and antibiotic associated diarrhoea (AAD),'1-it is very rarely isolated from extraintestinal specimens, especially pleuropulmonary specimens,4 and is very rarely a cause of extraintestinal infection.5 Large outbreaks of AAC/AAD have occurred in hospitals6 and most cases of intestinal infection follow nosocomial acquisition of the organism.7 Such acquisition is likely in this patient, causing an empyema secondary to attempted drainage of a pleural effusion, although a primary aspiration pleuropneumonia cannot be excluded. The latter possibility seems less likely as the previous pleural fluid specimens were sterile, but we have no other satisfactory explanation for his chest disease. However, there were no cases of C difficile associated diarrhoea on the same ward during his stay in this hospital. Pleuropulmonary infections with other clostridial species, usually C perfringens, have been reported occasionally.8 Very few cases ofpleural infection with C difficile have been reported, the first two cases being described in 1962. 9 Pleural infections caused by clostridial species seem to behave clinically like empyemas due to other causes.'0 In this case the process seems to have been relatively benign, assuming that this was a secondary infection and not the cause of the patient's underlying chest disease.
We suggest that isolation of C difficile from extraintestinal sites should not be ignored and that its recognition as a nosocomial pathogen be extended beyond its role in AAD and PMC.
We thank Dr A W Nathan for permission to report this case. 
MICROBIOLOGICAL STUDIES
The patient's faeces were plated on the media used for routine culture of this type of sample. After 24 hours of incubation we observed the growth of abundant colonies which were mannitol positive on cefsulodin-irgasan-novobiocin (CIN) agar (bioMerieux). The colonies were isolated in blood agar (5% sheep erythrocytes) and species identification was carried out with the API 20E (bioMerieux) and GNI card (Vitek bioMerieux) systems, and the manual tests of glucose gas production in triple-sugar-iron agar and esculin hydrolysis. The colonies were nonhaemolytic and were made up of Gram negative, motile, oxidase and catalase positive rods. The strain was identified as A sobria by both systems (bionumber 7246105 and 7020601235 respectively). In view of its sucrose negative character, the complementary cellobiose fermentation and gluconate oxidation tests were performed.8 Table 1 shows the principal biochemical characteristics of the strain isolated.
The antibiotic susceptibility study was carried out with the GNS-F3 and GNS-F6 cards (Vitek bioMerieux), the Pasco MIC/ID system (Difco), and the disk diffusion method for the ampicillin (10 jg), carbenicillin (100 gg), cephalothin (30,g), and colistin (10 gg) (Osoid). The strain was susceptible to ampicillin and carbenicillin by both methods (MICs of 1 jg/ml and <16 gg/ml) and to the rest of antibiotics studied except cephalothin (MIC >32 jg/ml), cefazolin (MIC >32 gg/ml), and cefonicid (MIC >16 jg/ml), and moderately to cefamandole (MIC 16 gg/ml). The set of biochemical tests performed together with the susceptibility pattern provided the final identification of A trota. The biochemical characteristics of A trota correspond to the A sobria phenotype (glucose gas positive and esculin hydrolysis negative). However, negative Voges-Proskauer and sucrose fermentation tests suggested the presence of this new species. A study of cellobiose fermentation, gluconate oxidation, and ampicillin and carbenicillin susceptibility enable us to differentiate A trota from A sobria (table 2).
Discussion
The mesophilic aeromonads group forms a part of the natural environment and may be isolated as normal flora of most water systems, tap water, rivers, streams, and canals. Human infections caused by Aeromonas spp may be grouped as gastrointestinal (diarrhoea) and extraintestinal, the former being the most common. There are geographical differences in the distribution of Aeromonas. In the temperate climates of Australia, A sobria is commonly isolated from stools of symptomatic patients; in other countries, such as the USA, the A hydrophila species is predominant.8
In our geographical area the incidence of diarrhoea caused by A trota is very low. In the period 1983-1994 we have isolated 700 mesophilic aeromonads in the faeces of paediatric patients with gastroenteritis and only one was identified as A trota, an incidence of 0-14%. The strains ofA trota described in published reports were almost all isolated in human faeces, with the exception of one strain which was isolated from a human appendix.8 There is only one case in which this new species has been shown to be implicated in diarrhoea. This was the case of a 28 year old laboratory worker with no previous history of diarrhoea. The infection was brought about by the accidental ingestion of a suspension of the strain ATCC 49657T (AH2), and caused a secretory diarrhoea with rice water stools over a period of two days. The diarrhoea was self limiting and disappeared after two days without any further complications.8 In our case the patient was a 3 year old boy with a mucous diarrhoea not associated with other clinical manifestations. It would seem, therefore, that the enteropathogenic capacity of A trota is not high, although Carnahan et al8 found that the AH2 strain showed mannose sensitive haemagglutination, and the sterile, filtered culture supernatants possessed haemolytic activity on human erythrocytes, cytolytic activity on Vero cells, and proteolytic activity on tryptic soy agar with added skimmed milk; all of these properties are recognised as virulence factors.9 Recently Husslein et al'0 showed that their AH2 strain had haemolytic activity against human erythrocytes and cytolytic activity on Vero cells. Our strain was non-haemolytic on blood agar with 5% sheep's erythrocytes but haemolytic on blood agar with 5% human erythrocytes.
The isolation ofA trota in the Mediterranean area confirms the suspicion of wordwide distribution of this species. It may be that one of the factors contributing to the difficulty in isolating this species is its susceptibility to ampicillin. Of the two media recommended for the preferential isolation of Aeromonas, blood agar with 10 gg/ml of ampicillin and CIN agar,5 only the latter would permit the isolation of A trota. In our laboratory, because of the presence of 15% of ampicillin susceptible Aeromonas strains in our area (MIC <8 gg/ml), we use the CIN agar for the simultaneous isolation of the genera Aeromonas and Yersinia.1" The use of a media without ampicillin would enable us to ascertain the true distribution and clinical significance of the new species, A trota. 
